Pluristyx
Seattle, United States · Biotechnology · 14 employees
Pluristyx is a pioneering company at the forefront of stem cell technologies. With a mission to revolutionize the field of regenerative medicine, Pluristyx develops innovative solutions that empower breakthroughs in stem cell therapies. The company's proprietary platform, panCELLa, represents a transformative leap in stem cell research, offering enhanced freedom to operate and unparalleled potenti
Funding history
- Venture - Series Unknown — $9.8M — Jul 2026
- Funding Round — Undisclosed — Jul 2025
- Funding Round — Undisclosed — Dec 2023
Recent signals
- Jul 13, 2026: Raised $9.8M in Venture - Series Unknown
- Jul 28, 2025: Raised funding in Funding Round
- Dec 21, 2023: Raised funding in Funding Round
See plans & pricing → Track Pluristyx’s funding, hiring, and signals — with verified contacts — on Fundz.